Characteristic | Univariable | Multivariable | ||||
---|---|---|---|---|---|---|
OR | 95% CI | p-value | OR | 95% CI | p-value | |
Age | 1.04 | 1.02, 1.06 | < 0.001 | 1.04 | 1.01, 1.06 | 0.002 |
Gender | ||||||
Male | Reference | Reference | ||||
Female | 1.37 | 0.70, 2.68 | 0.354 | |||
Blood group | ||||||
A- | Reference | Reference | ||||
A+ | 0.37 | 0.08, 1.96 | 0.202 | |||
B- | 0.00 | NA | 0.992 | |||
B+ | 0.56 | 0.13, 2.91 | 0.449 | |||
AB- | 0.00 | NA | 0.994 | |||
AB+ | 0.00 | NA | 0.991 | |||
O- | 0.00 | NA | 0.993 | |||
O+ | 0.75 | 0.20, 3.62 | 0.685 | |||
Pre-transplantation BMI | ||||||
< 18.5 | Reference | Reference | ||||
18.5–24.9 | 0.70 | 0.22, 2.70 | 0.569 | |||
25–29.9 | 1.27 | 0.40, 4.85 | 0.703 | |||
30–34.9 | 1.81 | 0.53, 7.32 | 0.367 | |||
35 or more | 1.50 | 0.18, 9.62 | 0.676 | |||
Post-transplantation BMI | ||||||
< 18.5 | Reference | Reference | ||||
18.5–24.9 | 1.38 | 0.32, 9.56 | 0.696 | |||
25–29.9 | 1.64 | 0.41, 11.1 | 0.535 | |||
30–34.9 | 1.95 | 0.45, 13.6 | 0.420 | |||
35 or more | 2.35 | 0.44, 18.1 | 0.345 | |||
Chronic conditions | ||||||
HTN | 1.23 | 0.55, 3.02 | 0.629 | |||
Anemia | 0.74 | 0.11, 2.81 | 0.697 | |||
Hyperlipidemia | 1.16 | 0.32, 3.36 | 0.795 | |||
Hepatitis B | 0.48 | 0.03, 2.59 | 0.484 | |||
Hepatitis C | 0.00 | NA | 0.990 | |||
Cancer | 0.00 | NA | 0.989 | |||
SLE | 0.69 | 0.04, 4.03 | 0.732 | |||
CMV | 1.14 | 0.25, 3.73 | 0.848 | |||
Cause of ESKD | ||||||
HTN | Reference | Reference | Reference | Reference | ||
Glomerulonephritis | 0.21 | 0.05, 0.77 | 0.017 | 0.32 | 0.08, 1.27 | 0.100 |
Graft failure | 0.50 | 0.02, 5.06 | 0.585 | 0.66 | 0.03, 7.24 | 0.749 |
Polycystic kidney disease (ARPKD) | 1.50 | 0.05, 43.2 | 0.788 | 3.91 | 0.13, 121 | 0.381 |
Polycystic kidney disease (ADPKD) | 0.19 | 0.01, 1.44 | 0.158 | 0.18 | 0.01, 1.44 | 0.153 |
Unknown | 0.36 | 0.12, 1.16 | 0.076 | 0.48 | 0.15, 1.65 | 0.224 |
Other | 0.13 | 0.02, 0.57 | 0.009 | 0.19 | 0.03, 0.92 | 0.045 |
Type of dialysis | ||||||
Not on dialysis | Reference | Reference | ||||
Hemodialysis | 1.23 | 0.44, 4.40 | 0.717 | |||
Peritoneal dialysis | 1.44 | 0.37, 6.23 | 0.605 | |||
Duration of dialysis (months) | 1.00 | 0.98, 1.01 | 0.622 | |||
Admission /Baseline serum creatinine | 1.00 | 1.00, 1.00 | 0.426 | |||
Type of immunotherapy used | ||||||
Tacrolimus + Steroid + MMF | Reference | Reference | ||||
Tacrolimus + Steroid | 1.57 | 0.49, 4.30 | 0.406 | |||
Tacrolimus | 0.00 | NA | 0.989 | |||
Cyclosporine | 0.00 | NA | 0.992 | |||
Duration of immunosuppression (all drugs) (years) | 0.97 | 0.81, 1.18 | 0.792 | |||
Complications | ||||||
UTI | 0.45 | 0.13, 1.20 | 0.148 | |||
CMV | 0.61 | 0.26, 1.31 | 0.230 | |||
BK | 0.94 | 0.33, 2.27 | 0.890 | |||
HCV | 0.00 | NA | 0.988 | |||
Polycythemia | 0.81 | 0.04, 4.91 | 0.846 | |||
AKI | 1.89 | 0.40, 6.88 | 0.361 | |||
Perirenal fluid collections | 2.05 | 0.54, 6.50 | 0.244 | |||
Herpes | 5.07 | 0.59, 43.3 | 0.109 | |||
Anemia | 0.00 | NA | 0.990 | |||
Hypertension | 1.23 | 0.06, 8.55 | 0.857 | |||
Graft rejection episodes | ||||||
Stable graft function | Reference | Reference | ||||
Acute rejection | 0.00 | 0.985 |